Sublingual administration of buprenorphine for long-term analgesia in the horse

Veterinary Record

Volumn 160, Issue 23, 2007, Pages 808-809

  Walker, A F ^a  

^a Strathy and Isaacs   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

EID: 34250839998     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.160.23.808     Document Type: Article

References (27)

1. ANON (2004) Methadone for Pain Guidelines. Toronto, College of Physicians and Surgeons of Ontario, pp 13-24. www.cpso.on.ca/publications/methpain.pdf. Accessed June 4, 2007
2. BULLINGHAM, R. E. S., MCQUAY, H. J., DWYER, D., ALLEN, M. C. & MOORE, R. A. (1981) Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis. British Journal of Clinical Pharmacology 12, 117-122
3. BULLINGHAM, R. E. S., MCQUAY, H. J., PORTER, E. J. B., ALLEN, M. C. & MOORE, R. A. (1982) Sublingual buprenorphine used postoperatively: ten-hour plasma drug concentration analysis. British Journal of Clinical Pharmacology 13, 665-673
4. COWAN, A. (1995) Update on the general pharmacology of buprenorphine. In Buprenorphine: Combating Drug Abuse with a Unique Opioid. Eds A. Cowan, I. W. Lewis. New York, Toronto, Wiley-Liss. pp 31-47
5. COWAN, A., DOXEY, J. C. & HARRY, E. J. R. (1977a) The animal pharmacology of buprenorphine, an oripavine analgesic agent. British Journal of Pharmacology 60, 547-554
6. COWAN, A., LEWIS, J. W. & MACFARLANE, I. R. (1977b) Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. British Journal of Pharmacology 60, 537-545
7. FREEMAN, S. L. & ENGLAND, G. C. W. (1999) Comparison of sedative effects of romifidine following intravenous, intramuscular, and sublingual administration to horses. American Journal of Veterinary Research 60, 954-959
8. HALL, L. W., CLARKE, K. W. & TRIM, C. M. (2001a) Sedation, analgesia and premedication. In Veterinary Anaesthesia. 10th edn. Toronto, W. B. Saunders. pp 99-100
9. HALL, L. W., CLARKE, K. W. & TRIM, C. M. (2001b) The horse. In Veterinary Anaesthesia. 10th edn. Toronto, W. B. Saunders. pp 254-257
10. HARRIS, D. & ROBINSON, J. R. (1992) Drug delivery via the mucous membranes of the oral cavity. Journal of Pharmaceutical Sciences 81, 1-10
11. JASINSKI, D. R., PEVNICK, J. S. & GRIFFITH, J. D. (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. Archives of General Psychiatry 35, 501-516
12. KAHAN, M., WILSON, L & GOURLAY, D. (2000) Prevention, diagnosis and treatment of opioid dependence in patients with chronic non-malignant pain. In Management of Alcohol, Tobacco and Other Drug Problems: a Physician's Manual. Ed B. Brands. Toronto, Centre for Addiction and Mental Health, pp 247-282
13. KUHLMAN, J. J., JR., LALANI, S., MAGLUILO, J., JR., LEVINE, B., DARWIN, W. D., JOHNSON, R. E. & CONE, E. J. (1996) Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. Journal of Analytical Toxicology 20, 369-378
14. MALONE, J. H. & CLARKE, K. W. (1993) A comparison of the efficacy of detomidine by sublingual and intramuscular administration in ponies. Journal of Veterinary Anaesthesia 20, 73-77
15. MCQUAY, H. J. & MOORE, R. A. (1995) Buprenorphine kinetics in humans. In Buprenorphine: Combating Drug Abuse with a Unique Opioid. Eds A. Cowan, J. W. Lewis. New York, Toronto, Wiley-Liss. pp 137-147
16. MELLO, N. K. & MENDELSON, J. H. (1980) Buprenorphine suppresses heroin use by heroin addicts. Science 207, 657-659
17. MENDELSON, J., UPTON, R. A., EVERHART, E. T., JACOB, P., III & JONES, R. T. (1997) Bioavailability of sublingual buprenorphine. Journal of Clinical Pharmacology 37, 31-37
18. NOLAN, A. M. & HALL, L. W. (1984) Combined use of sedatives and opiates in horses. Veterinary Record 114, 63-67
19. RAMSAY, E. C., GEISER, D., CARTER, W. & TOBIN, T. (2002) Serum concentrations and effects of detomidine delivered orally to horses in three different mediums. Veterinary Anaesthesia and Analgesia 29, 219-222
20. ROBERTSON, S. A., TAYLOR, P. M. & SEAR, J. W. (2003) Systemic uptake of buprenorphine by cats after oral mucosal administration. Veterinary Record 152, 675-678
21. ROBERTSON, S. A., TAYLOR, P. M., SEAR, J. W. & LASCELLES B. D. X. (2005) PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. Journal of Veterinary Pharmacology and Therapeutics 28, 453-460
22. SCHUH, K. J. & JOHANSON, C-E. (1999) Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. Drug and Alcohol Dependence 56, 55-60
23. SZÖKE, M. O., BLAIS, D., CUVELLIEZ, S. G. & LAVOIE, J-P. (1998) Effects of buprenorphine on cardiovascular and pulmonary function in clinically normal horses and horses with chronic obstructive pulmonary disease. American Journal of Veterinary Research 59, 1287-1291
24. TAYLOR, P. M. & CLARKE, K. W. (1999) Sedation, analgesia and premedication. In Handbook of Equine Anaesthesia. Toronto, W. B. Saunders. pp 24-25
25. THURMON, J. C. & BENSON, G. J. (1987) Injectable anesthetics and anesthetic adjuncts. Veterinary Clinics of North America: Equine Practice 3, 15-36
26. THURMON, J. C., TRANQUILLI, W. J. & BENSON, G. J. (1996) Perioperative pain and distress. In Lumb & Jones' Veterinary Anesthesia. 3rd edn. Eds J. C. Thurman, W. J. Tranquilli, G. J. Benson. Baltimore, Williams & Wilkins. pp 53-57
27. WEINBERG, D. S., INTURRISI, C. E., REIDENBERG, B., MOULIN, D. E., NIP, T. J., WALLENSTEIN, S., HOUDE, R. W. & FOLEY, K. M. (1988) Sublingual absorption of selected opioid analgesics. Clinical Pharmacology and Therapeutics 44, 335-342